The global Paclitaxel market is projected to grow from US$ 128.1 million in 2023 to US$ 205.5 million by 2029, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.

Paclitaxel Market

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.

Report Includes:

This report presents an overview of global market for Paclitaxel, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Paclitaxel, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Paclitaxel, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Paclitaxel sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Paclitaxel market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Paclitaxel sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma and Southpharma, etc.

Scope of Paclitaxel Market Report

Report Metric	Details
Report Name	Paclitaxel Market
Accounted market size in 2023	US$ 128.1 million
Forecasted market size in 2029	US$ 205.5 million
CAGR	8.2
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Natural Paclitaxel API Semi-synthetic Paclitaxel API
Segment by Application	Ovarian Cancer Cervical Cancer Breast Cancer Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Paclitaxel in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Paclitaxel manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Paclitaxel sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Paclitaxel Market growing?

Ans: The Paclitaxel Market witnessing a CAGR of 8.2 during the forecast period 2023-2029.

What is the Paclitaxel Market size in 2029?

Ans: The Paclitaxel Market size in 2029 will be US$ 205.5 million.

What is the Paclitaxel Market production share by region?

Ans: North America and China are the largest producer of Paclitaxel, with a market share about 35% separately.

What is the market share of major companies in Paclitaxel Market?

Ans: Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.

Who are the main players in the Paclitaxel Market report?

Ans: The main players in the Paclitaxel Market are Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology

What are the Application segmentation covered in the Paclitaxel Market report?

Ans: The Applications covered in the Paclitaxel Market report are Ovarian Cancer, Cervical Cancer, Breast Cancer, Others

What are the Type segmentation covered in the Paclitaxel Market report?

Ans: The Types covered in the Paclitaxel Market report are Natural Paclitaxel API, Semi-synthetic Paclitaxel API

1 Study Coverage

1.1 Paclitaxel Product Introduction

1.2 Market by Type

1.2.1 Global Paclitaxel Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Natural Paclitaxel API

1.2.3 Semi-synthetic Paclitaxel API

1.3 Market by Application

1.3.1 Global Paclitaxel Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Ovarian Cancer

1.3.3 Cervical Cancer

1.3.4 Breast Cancer

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Paclitaxel Sales Estimates and Forecasts 2018-2029

2.2 Global Paclitaxel Revenue by Region

2.2.1 Global Paclitaxel Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Paclitaxel Revenue by Region (2018-2023)

2.2.3 Global Paclitaxel Revenue by Region (2024-2029)

2.2.4 Global Paclitaxel Revenue Market Share by Region (2018-2029)

2.3 Global Paclitaxel Sales Estimates and Forecasts 2018-2029

2.4 Global Paclitaxel Sales by Region

2.4.1 Global Paclitaxel Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Paclitaxel Sales by Region (2018-2023)

2.4.3 Global Paclitaxel Sales by Region (2024-2029)

2.4.4 Global Paclitaxel Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Paclitaxel Sales by Manufacturers

3.1.1 Global Paclitaxel Sales by Manufacturers (2018-2023)

3.1.2 Global Paclitaxel Sales Market Share by Manufacturers (2018-2023)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Paclitaxel in 2022

3.2 Global Paclitaxel Revenue by Manufacturers

3.2.1 Global Paclitaxel Revenue by Manufacturers (2018-2023)

3.2.2 Global Paclitaxel Revenue Market Share by Manufacturers (2018-2023)

3.2.3 Global Top 10 and Top 5 Companies by Paclitaxel Revenue in 2022

3.3 Global Key Players of Paclitaxel, Industry Ranking, 2021 VS 2022 VS 2023

3.4 Global Paclitaxel Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Paclitaxel Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Paclitaxel, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Paclitaxel, Product Offered and Application

3.8 Global Key Manufacturers of Paclitaxel, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Paclitaxel Sales by Type

4.1.1 Global Paclitaxel Historical Sales by Type (2018-2023)

4.1.2 Global Paclitaxel Forecasted Sales by Type (2024-2029)

4.1.3 Global Paclitaxel Sales Market Share by Type (2018-2029)

4.2 Global Paclitaxel Revenue by Type

4.2.1 Global Paclitaxel Historical Revenue by Type (2018-2023)

4.2.2 Global Paclitaxel Forecasted Revenue by Type (2024-2029)

4.2.3 Global Paclitaxel Revenue Market Share by Type (2018-2029)

4.3 Global Paclitaxel Price by Type

4.3.1 Global Paclitaxel Price by Type (2018-2023)

4.3.2 Global Paclitaxel Price Forecast by Type (2024-2029)

5 Market Size by Application

5.1 Global Paclitaxel Sales by Application

5.1.1 Global Paclitaxel Historical Sales by Application (2018-2023)

5.1.2 Global Paclitaxel Forecasted Sales by Application (2024-2029)

5.1.3 Global Paclitaxel Sales Market Share by Application (2018-2029)

5.2 Global Paclitaxel Revenue by Application

5.2.1 Global Paclitaxel Historical Revenue by Application (2018-2023)

5.2.2 Global Paclitaxel Forecasted Revenue by Application (2024-2029)

5.2.3 Global Paclitaxel Revenue Market Share by Application (2018-2029)

5.3 Global Paclitaxel Price by Application

5.3.1 Global Paclitaxel Price by Application (2018-2023)

5.3.2 Global Paclitaxel Price Forecast by Application (2024-2029)

6 US & Canada

6.1 US & Canada Paclitaxel Market Size by Type

6.1.1 US & Canada Paclitaxel Sales by Type (2018-2029)

6.1.2 US & Canada Paclitaxel Revenue by Type (2018-2029)

6.2 US & Canada Paclitaxel Market Size by Application

6.2.1 US & Canada Paclitaxel Sales by Application (2018-2029)

6.2.2 US & Canada Paclitaxel Revenue by Application (2018-2029)

6.3 US & Canada Paclitaxel Market Size by Country

6.3.1 US & Canada Paclitaxel Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Paclitaxel Sales by Country (2018-2029)

6.3.3 US & Canada Paclitaxel Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Paclitaxel Market Size by Type

7.1.1 Europe Paclitaxel Sales by Type (2018-2029)

7.1.2 Europe Paclitaxel Revenue by Type (2018-2029)

7.2 Europe Paclitaxel Market Size by Application

7.2.1 Europe Paclitaxel Sales by Application (2018-2029)

7.2.2 Europe Paclitaxel Revenue by Application (2018-2029)

7.3 Europe Paclitaxel Market Size by Country

7.3.1 Europe Paclitaxel Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Paclitaxel Sales by Country (2018-2029)

7.3.3 Europe Paclitaxel Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Paclitaxel Market Size

8.1.1 China Paclitaxel Sales (2018-2029)

8.1.2 China Paclitaxel Revenue (2018-2029)

8.2 China Paclitaxel Market Size by Application

8.2.1 China Paclitaxel Sales by Application (2018-2029)

8.2.2 China Paclitaxel Revenue by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Paclitaxel Market Size by Type

9.1.1 Asia Paclitaxel Sales by Type (2018-2029)

9.1.2 Asia Paclitaxel Revenue by Type (2018-2029)

9.2 Asia Paclitaxel Market Size by Application

9.2.1 Asia Paclitaxel Sales by Application (2018-2029)

9.2.2 Asia Paclitaxel Revenue by Application (2018-2029)

9.3 Asia Paclitaxel Sales by Region

9.3.1 Asia Paclitaxel Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Paclitaxel Revenue by Region (2018-2029)

9.3.3 Asia Paclitaxel Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Paclitaxel Market Size by Type

10.1.1 Middle East, Africa and Latin America Paclitaxel Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Paclitaxel Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Paclitaxel Market Size by Application

10.2.1 Middle East, Africa and Latin America Paclitaxel Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Paclitaxel Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Paclitaxel Sales by Country

10.3.1 Middle East, Africa and Latin America Paclitaxel Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Paclitaxel Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Paclitaxel Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Phyton

11.1.1 Phyton Company Information

11.1.2 Phyton Overview

11.1.3 Phyton Paclitaxel Sales, Price, Revenue and Gross Margin (2018-2023)

11.1.4 Phyton Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Phyton Recent Developments

11.2 ScinoPharm

11.2.1 ScinoPharm Company Information

11.2.2 ScinoPharm Overview

11.2.3 ScinoPharm Paclitaxel Sales, Price, Revenue and Gross Margin (2018-2023)

11.2.4 ScinoPharm Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 ScinoPharm Recent Developments

11.3 Novasep

11.3.1 Novasep Company Information

11.3.2 Novasep Overview

11.3.3 Novasep Paclitaxel Sales, Price, Revenue and Gross Margin (2018-2023)

11.3.4 Novasep Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Novasep Recent Developments

11.4 Samyang

11.4.1 Samyang Company Information

11.4.2 Samyang Overview

11.4.3 Samyang Paclitaxel Sales, Price, Revenue and Gross Margin (2018-2023)

11.4.4 Samyang Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Samyang Recent Developments

11.5 Polymed

11.5.1 Polymed Company Information

11.5.2 Polymed Overview

11.5.3 Polymed Paclitaxel Sales, Price, Revenue and Gross Margin (2018-2023)

11.5.4 Polymed Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Polymed Recent Developments

11.6 TAPI (Teva)

11.6.1 TAPI (Teva) Company Information

11.6.2 TAPI (Teva) Overview

11.6.3 TAPI (Teva) Paclitaxel Sales, Price, Revenue and Gross Margin (2018-2023)

11.6.4 TAPI (Teva) Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 TAPI (Teva) Recent Developments

11.7 Fresenius-kabi

11.7.1 Fresenius-kabi Company Information

11.7.2 Fresenius-kabi Overview

11.7.3 Fresenius-kabi Paclitaxel Sales, Price, Revenue and Gross Margin (2018-2023)

11.7.4 Fresenius-kabi Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Fresenius-kabi Recent Developments

11.8 Huiang biopharma

11.8.1 Huiang biopharma Company Information

11.8.2 Huiang biopharma Overview

11.8.3 Huiang biopharma Paclitaxel Sales, Price, Revenue and Gross Margin (2018-2023)

11.8.4 Huiang biopharma Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Huiang biopharma Recent Developments

11.9 Southpharma

11.9.1 Southpharma Company Information

11.9.2 Southpharma Overview

11.9.3 Southpharma Paclitaxel Sales, Price, Revenue and Gross Margin (2018-2023)

11.9.4 Southpharma Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Southpharma Recent Developments

11.10 Yunnan Hande

11.10.1 Yunnan Hande Company Information

11.10.2 Yunnan Hande Overview

11.10.3 Yunnan Hande Paclitaxel Sales, Price, Revenue and Gross Margin (2018-2023)

11.10.4 Yunnan Hande Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Yunnan Hande Recent Developments

11.11 Hainan Yew Pharm

11.11.1 Hainan Yew Pharm Company Information

11.11.2 Hainan Yew Pharm Overview

11.11.3 Hainan Yew Pharm Paclitaxel Sales, Price, Revenue and Gross Margin (2018-2023)

11.11.4 Hainan Yew Pharm Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Hainan Yew Pharm Recent Developments

11.12 Jiangsu Yew Biotechnology

11.12.1 Jiangsu Yew Biotechnology Company Information

11.12.2 Jiangsu Yew Biotechnology Overview

11.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Price, Revenue and Gross Margin (2018-2023)

11.12.4 Jiangsu Yew Biotechnology Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Jiangsu Yew Biotechnology Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Paclitaxel Industry Chain Analysis

12.2 Paclitaxel Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Paclitaxel Production Mode & Process

12.4 Paclitaxel Sales and Marketing

12.4.1 Paclitaxel Sales Channels

12.4.2 Paclitaxel Distributors

12.5 Paclitaxel Customers

13 Market Dynamics

13.1 Paclitaxel Industry Trends

13.2 Paclitaxel Market Drivers

13.3 Paclitaxel Market Challenges

13.4 Paclitaxel Market Restraints

14 Key Findings in The Global Paclitaxel Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Jiangsu Yew Biotechnology

Southpharma

Novasep

Phyton

List of Tables

Table 1. Global Paclitaxel Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Table 2. Major Manufacturers of Natural Paclitaxel API

Table 3. Major Manufacturers of Semi-synthetic Paclitaxel API

Table 4. Global Paclitaxel Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Table 5. Global Paclitaxel Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 6. Global Paclitaxel Revenue by Region (2018-2023) & (US$ Million)

Table 7. Global Paclitaxel Revenue by Region (2024-2029) & (US$ Million)

Table 8. Global Paclitaxel Revenue Market Share by Region (2018-2023)

Table 9. Global Paclitaxel Revenue Market Share by Region (2024-2029)

Table 10. Global Paclitaxel Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 11. Global Paclitaxel Sales by Region (2018-2023) & (Kg)

Table 12. Global Paclitaxel Sales by Region (2024-2029) & (Kg)

Table 13. Global Paclitaxel Sales Market Share by Region (2018-2023)

Table 14. Global Paclitaxel Sales Market Share by Region (2024-2029)

Table 15. Global Paclitaxel Sales by Manufacturers (2018-2023) & (Kg)

Table 16. Global Paclitaxel Sales Share by Manufacturers (2018-2023)

Table 17. Global Paclitaxel Revenue by Manufacturers (2018-2023) & (US$ Million)

Table 18. Global Paclitaxel Revenue Share by Manufacturers (2018-2023)

Table 19. Global Key Players of Paclitaxel, Industry Ranking, 2021 VS 2022 VS 2023

Table 20. Paclitaxel Price by Manufacturers 2018-2023 (USD/Kg)

Table 21. Global Paclitaxel Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Paclitaxel by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel as of 2022)

Table 23. Global Key Manufacturers of Paclitaxel, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Paclitaxel, Product Offered and Application

Table 25. Global Key Manufacturers of Paclitaxel, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Paclitaxel Sales by Type (2018-2023) & (Kg)

Table 28. Global Paclitaxel Sales by Type (2024-2029) & (Kg)

Table 29. Global Paclitaxel Sales Share by Type (2018-2023)

Table 30. Global Paclitaxel Sales Share by Type (2024-2029)

Table 31. Global Paclitaxel Revenue by Type (2018-2023) & (US$ Million)

Table 32. Global Paclitaxel Revenue by Type (2024-2029) & (US$ Million)

Table 33. Global Paclitaxel Revenue Share by Type (2018-2023)

Table 34. Global Paclitaxel Revenue Share by Type (2024-2029)

Table 35. Paclitaxel Price by Type (2018-2023) & (USD/Kg)

Table 36. Global Paclitaxel Price Forecast by Type (2024-2029) & (USD/Kg)

Table 37. Global Paclitaxel Sales by Application (2018-2023) & (Kg)

Table 38. Global Paclitaxel Sales by Application (2024-2029) & (Kg)

Table 39. Global Paclitaxel Sales Share by Application (2018-2023)

Table 40. Global Paclitaxel Sales Share by Application (2024-2029)

Table 41. Global Paclitaxel Revenue by Application (2018-2023) & (US$ Million)

Table 42. Global Paclitaxel Revenue by Application (2024-2029) & (US$ Million)

Table 43. Global Paclitaxel Revenue Share by Application (2018-2023)

Table 44. Global Paclitaxel Revenue Share by Application (2024-2029)

Table 45. Paclitaxel Price by Application (2018-2023) & (USD/Kg)

Table 46. Global Paclitaxel Price Forecast by Application (2024-2029) & (USD/Kg)

Table 47. US & Canada Paclitaxel Sales by Type (2018-2023) & (Kg)

Table 48. US & Canada Paclitaxel Sales by Type (2024-2029) & (Kg)

Table 49. US & Canada Paclitaxel Revenue by Type (2018-2023) & (US$ Million)

Table 50. US & Canada Paclitaxel Revenue by Type (2024-2029) & (US$ Million)

Table 51. US & Canada Paclitaxel Sales by Application (2018-2023) & (Kg)

Table 52. US & Canada Paclitaxel Sales by Application (2024-2029) & (Kg)

Table 53. US & Canada Paclitaxel Revenue by Application (2018-2023) & (US$ Million)

Table 54. US & Canada Paclitaxel Revenue by Application (2024-2029) & (US$ Million)

Table 55. US & Canada Paclitaxel Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 56. US & Canada Paclitaxel Revenue by Country (2018-2023) & (US$ Million)

Table 57. US & Canada Paclitaxel Revenue by Country (2024-2029) & (US$ Million)

Table 58. US & Canada Paclitaxel Sales by Country (2018-2023) & (Kg)

Table 59. US & Canada Paclitaxel Sales by Country (2024-2029) & (Kg)

Table 60. Europe Paclitaxel Sales by Type (2018-2023) & (Kg)

Table 61. Europe Paclitaxel Sales by Type (2024-2029) & (Kg)

Table 62. Europe Paclitaxel Revenue by Type (2018-2023) & (US$ Million)

Table 63. Europe Paclitaxel Revenue by Type (2024-2029) & (US$ Million)

Table 64. Europe Paclitaxel Sales by Application (2018-2023) & (Kg)

Table 65. Europe Paclitaxel Sales by Application (2024-2029) & (Kg)

Table 66. Europe Paclitaxel Revenue by Application (2018-2023) & (US$ Million)

Table 67. Europe Paclitaxel Revenue by Application (2024-2029) & (US$ Million)

Table 68. Europe Paclitaxel Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 69. Europe Paclitaxel Revenue by Country (2018-2023) & (US$ Million)

Table 70. Europe Paclitaxel Revenue by Country (2024-2029) & (US$ Million)

Table 71. Europe Paclitaxel Sales by Country (2018-2023) & (Kg)

Table 72. Europe Paclitaxel Sales by Country (2024-2029) & (Kg)

Table 73. China Paclitaxel Sales by Type (2018-2023) & (Kg)

Table 74. China Paclitaxel Sales by Type (2024-2029) & (Kg)

Table 75. China Paclitaxel Revenue by Type (2018-2023) & (US$ Million)

Table 76. China Paclitaxel Revenue by Type (2024-2029) & (US$ Million)

Table 77. China Paclitaxel Sales by Application (2018-2023) & (Kg)

Table 78. China Paclitaxel Sales by Application (2024-2029) & (Kg)

Table 79. China Paclitaxel Revenue by Application (2018-2023) & (US$ Million)

Table 80. China Paclitaxel Revenue by Application (2024-2029) & (US$ Million)

Table 81. Asia Paclitaxel Sales by Type (2018-2023) & (Kg)

Table 82. Asia Paclitaxel Sales by Type (2024-2029) & (Kg)

Table 83. Asia Paclitaxel Revenue by Type (2018-2023) & (US$ Million)

Table 84. Asia Paclitaxel Revenue by Type (2024-2029) & (US$ Million)

Table 85. Asia Paclitaxel Sales by Application (2018-2023) & (Kg)

Table 86. Asia Paclitaxel Sales by Application (2024-2029) & (Kg)

Table 87. Asia Paclitaxel Revenue by Application (2018-2023) & (US$ Million)

Table 88. Asia Paclitaxel Revenue by Application (2024-2029) & (US$ Million)

Table 89. Asia Paclitaxel Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 90. Asia Paclitaxel Revenue by Region (2018-2023) & (US$ Million)

Table 91. Asia Paclitaxel Revenue by Region (2024-2029) & (US$ Million)

Table 92. Asia Paclitaxel Sales by Region (2018-2023) & (Kg)

Table 93. Asia Paclitaxel Sales by Region (2024-2029) & (Kg)

Table 94. Middle East, Africa and Latin America Paclitaxel Sales by Type (2018-2023) & (Kg)

Table 95. Middle East, Africa and Latin America Paclitaxel Sales by Type (2024-2029) & (Kg)

Table 96. Middle East, Africa and Latin America Paclitaxel Revenue by Type (2018-2023) & (US$ Million)

Table 97. Middle East, Africa and Latin America Paclitaxel Revenue by Type (2024-2029) & (US$ Million)

Table 98. Middle East, Africa and Latin America Paclitaxel Sales by Application (2018-2023) & (Kg)

Table 99. Middle East, Africa and Latin America Paclitaxel Sales by Application (2024-2029) & (Kg)

Table 100. Middle East, Africa and Latin America Paclitaxel Revenue by Application (2018-2023) & (US$ Million)

Table 101. Middle East, Africa and Latin America Paclitaxel Revenue by Application (2024-2029) & (US$ Million)

Table 102. Middle East, Africa and Latin America Paclitaxel Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 103. Middle East, Africa and Latin America Paclitaxel Revenue by Country (2018-2023) & (US$ Million)

Table 104. Middle East, Africa and Latin America Paclitaxel Revenue by Country (2024-2029) & (US$ Million)

Table 105. Middle East, Africa and Latin America Paclitaxel Sales by Country (2018-2023) & (Kg)

Table 106. Middle East, Africa and Latin America Paclitaxel Sales by Country (2024-2029) & (Kg)

Table 107. Phyton Company Information

Table 108. Phyton Description and Major Businesses

Table 109. Phyton Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 110. Phyton Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Phyton Recent Developments

Table 112. ScinoPharm Company Information

Table 113. ScinoPharm Description and Major Businesses

Table 114. ScinoPharm Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 115. ScinoPharm Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. ScinoPharm Recent Developments

Table 117. Novasep Company Information

Table 118. Novasep Description and Major Businesses

Table 119. Novasep Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 120. Novasep Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Novasep Recent Developments

Table 122. Samyang Company Information

Table 123. Samyang Description and Major Businesses

Table 124. Samyang Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 125. Samyang Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Samyang Recent Developments

Table 127. Polymed Company Information

Table 128. Polymed Description and Major Businesses

Table 129. Polymed Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 130. Polymed Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Polymed Recent Developments

Table 132. TAPI (Teva) Company Information

Table 133. TAPI (Teva) Description and Major Businesses

Table 134. TAPI (Teva) Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 135. TAPI (Teva) Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. TAPI (Teva) Recent Developments

Table 137. Fresenius-kabi Company Information

Table 138. Fresenius-kabi Description and Major Businesses

Table 139. Fresenius-kabi Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 140. Fresenius-kabi Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Fresenius-kabi Recent Developments

Table 142. Huiang biopharma Company Information

Table 143. Huiang biopharma Description and Major Businesses

Table 144. Huiang biopharma Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 145. Huiang biopharma Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Huiang biopharma Recent Developments

Table 147. Southpharma Company Information

Table 148. Southpharma Description and Major Businesses

Table 149. Southpharma Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 150. Southpharma Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Southpharma Recent Developments

Table 152. Yunnan Hande Company Information

Table 153. Yunnan Hande Description and Major Businesses

Table 154. Yunnan Hande Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 155. Yunnan Hande Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Yunnan Hande Recent Developments

Table 157. Hainan Yew Pharm Company Information

Table 158. Hainan Yew Pharm Description and Major Businesses

Table 159. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 160. Hainan Yew Pharm Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. Hainan Yew Pharm Recent Developments

Table 162. Jiangsu Yew Biotechnology Company Information

Table 163. Jiangsu Yew Biotechnology Description and Major Businesses

Table 164. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)

Table 165. Jiangsu Yew Biotechnology Paclitaxel Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. Jiangsu Yew Biotechnology Recent Developments

Table 167. Key Raw Materials Lists

Table 168. Raw Materials Key Suppliers Lists

Table 169. Paclitaxel Distributors List

Table 170. Paclitaxel Customers List

Table 171. Paclitaxel Market Trends

Table 172. Paclitaxel Market Drivers

Table 173. Paclitaxel Market Challenges

Table 174. Paclitaxel Market Restraints

Table 175. Research Programs/Design for This Report

Table 176. Key Data Information from Secondary Sources

Table 177. Key Data Information from Primary Sources

List of Figures

Figure 1. Paclitaxel Product Picture

Figure 2. Global Paclitaxel Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Paclitaxel Market Share by Type in 2022 & 2029

Figure 4. Natural Paclitaxel API Product Picture

Figure 5. Semi-synthetic Paclitaxel API Product Picture

Figure 6. Global Paclitaxel Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 7. Global Paclitaxel Market Share by Application in 2022 & 2029

Figure 8. Ovarian Cancer

Figure 9. Cervical Cancer

Figure 10. Breast Cancer

Figure 11. Others

Figure 12. Paclitaxel Report Years Considered

Figure 13. Global Paclitaxel Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 14. Global Paclitaxel Revenue 2018-2029 (US$ Million)

Figure 15. Global Paclitaxel Revenue Market Share by Region in Percentage: 2022 Versus 2029

Figure 16. Global Paclitaxel Revenue Market Share by Region (2018-2029)

Figure 17. Global Paclitaxel Sales 2018-2029 ((Kg)

Figure 18. Global Paclitaxel Sales Market Share by Region (2018-2029)

Figure 19. US & Canada Paclitaxel Sales YoY (2018-2029) & (Kg)

Figure 20. US & Canada Paclitaxel Revenue YoY (2018-2029) & (US$ Million)

Figure 21. Europe Paclitaxel Sales YoY (2018-2029) & (Kg)

Figure 22. Europe Paclitaxel Revenue YoY (2018-2029) & (US$ Million)

Figure 23. China Paclitaxel Sales YoY (2018-2029) & (Kg)

Figure 24. China Paclitaxel Revenue YoY (2018-2029) & (US$ Million)

Figure 25. Asia (excluding China) Paclitaxel Sales YoY (2018-2029) & (Kg)

Figure 26. Asia (excluding China) Paclitaxel Revenue YoY (2018-2029) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Paclitaxel Sales YoY (2018-2029) & (Kg)

Figure 28. Middle East, Africa and Latin America Paclitaxel Revenue YoY (2018-2029) & (US$ Million)

Figure 29. The Paclitaxel Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

Figure 30. The Top 5 and 10 Largest Manufacturers of Paclitaxel in the World: Market Share by Paclitaxel Revenue in 2022

Figure 31. Global Paclitaxel Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 32. Global Paclitaxel Sales Market Share by Type (2018-2029)

Figure 33. Global Paclitaxel Revenue Market Share by Type (2018-2029)

Figure 34. Global Paclitaxel Sales Market Share by Application (2018-2029)

Figure 35. Global Paclitaxel Revenue Market Share by Application (2018-2029)

Figure 36. US & Canada Paclitaxel Sales Market Share by Type (2018-2029)

Figure 37. US & Canada Paclitaxel Revenue Market Share by Type (2018-2029)

Figure 38. US & Canada Paclitaxel Sales Market Share by Application (2018-2029)

Figure 39. US & Canada Paclitaxel Revenue Market Share by Application (2018-2029)

Figure 40. US & Canada Paclitaxel Revenue Share by Country (2018-2029)

Figure 41. US & Canada Paclitaxel Sales Share by Country (2018-2029)

Figure 42. U.S. Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 43. Canada Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 44. Europe Paclitaxel Sales Market Share by Type (2018-2029)

Figure 45. Europe Paclitaxel Revenue Market Share by Type (2018-2029)

Figure 46. Europe Paclitaxel Sales Market Share by Application (2018-2029)

Figure 47. Europe Paclitaxel Revenue Market Share by Application (2018-2029)

Figure 48. Europe Paclitaxel Revenue Share by Country (2018-2029)

Figure 49. Europe Paclitaxel Sales Share by Country (2018-2029)

Figure 50. Germany Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 51. France Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 52. U.K. Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 53. Italy Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 54. Russia Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 55. China Paclitaxel Sales Market Share by Type (2018-2029)

Figure 56. China Paclitaxel Revenue Market Share by Type (2018-2029)

Figure 57. China Paclitaxel Sales Market Share by Application (2018-2029)

Figure 58. China Paclitaxel Revenue Market Share by Application (2018-2029)

Figure 59. Asia Paclitaxel Sales Market Share by Type (2018-2029)

Figure 60. Asia Paclitaxel Revenue Market Share by Type (2018-2029)

Figure 61. Asia Paclitaxel Sales Market Share by Application (2018-2029)

Figure 62. Asia Paclitaxel Revenue Market Share by Application (2018-2029)

Figure 63. Asia Paclitaxel Revenue Share by Region (2018-2029)

Figure 64. Asia Paclitaxel Sales Share by Region (2018-2029)

Figure 65. Japan Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 66. South Korea Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 67. China Taiwan Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 68. Southeast Asia Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 69. India Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Paclitaxel Sales Market Share by Type (2018-2029)

Figure 71. Middle East, Africa and Latin America Paclitaxel Revenue Market Share by Type (2018-2029)

Figure 72. Middle East, Africa and Latin America Paclitaxel Sales Market Share by Application (2018-2029)

Figure 73. Middle East, Africa and Latin America Paclitaxel Revenue Market Share by Application (2018-2029)

Figure 74. Middle East, Africa and Latin America Paclitaxel Revenue Share by Country (2018-2029)

Figure 75. Middle East, Africa and Latin America Paclitaxel Sales Share by Country (2018-2029)

Figure 76. Brazil Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 77. Mexico Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 78. Turkey Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 79. Israel Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 80. GCC Countries Paclitaxel Revenue (2018-2029) & (US$ Million)

Figure 81. Paclitaxel Value Chain

Figure 82. Paclitaxel Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions